Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04817644 · ClinicalTrials.gov registry record · Phase 1

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

A Phase 1 study of Diabetes Mellitus, Type 2, sponsored by Novo Nordisk A/S.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
2
Study locations

NCT04817644 is a Phase 1 study of Diabetes Mellitus, Type 2 that has completed, run by Novo Nordisk A/S. The registered enrollment target is 14 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04817644, a Phase 1 study of Diabetes Mellitus, Type 2, has completed, sponsored by Novo Nordisk A/S.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
2
Study locations

Study Summary

Participants in the study, will receive the study drug once daily for 10 days in tablet form for oral (by mouth) intake. On day 1 to 5 the tablet will contain 3 mg semaglutide, and on day 6-10 the tablet will contain 7 mg semaglutide.

Conditions Studied

Diabetes Mellitus, Type 2

Interventions

  • DRUG Oral semaglutide

Study Locations (2)

Texas

  • ICON Early Phase Services, LLC - San Antonio

Utah

  • ICON-Salt Lake City - Salt Lake City

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-09-10
Est. Completion 2023-07-03
Phase Phase 1

Sponsor

Novo Nordisk A/S

431 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04817644

The ClinicalTrials.gov registry entry for NCT04817644 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (100% lower). The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Oral semaglutide is the first listed.

NCT04817644 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Utah.

Frequently Asked Questions

What is clinical trial NCT04817644 about?

NCT04817644 is a clinical study titled "A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets". Participants in the study, will receive the study drug once daily for 10 days in tablet form for oral (by mouth) intake. On day 1 to 5 the tablet will contain 3 mg semaglutide, and on day 6-10 the tablet will contain 7 mg semaglutide.

What is the current status of trial NCT04817644?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2021-09-10. Estimated completion is 2023-07-03.

What conditions does trial NCT04817644 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT04817644?

The interventions under investigation include: Oral semaglutide (DRUG).

Who is sponsoring clinical trial NCT04817644?

This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04817644 being conducted?

This trial has 2 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.